Optimal control strategies for SGLT2 inhibitors as a novel anti-tumor agent and their effect on human breast cancer cells with the effect of time delay and hyperglycemia
Breast cancer is the most frequent cancer in the world, and it continues to have a significant impact on the total number of cancer deaths. Recently, oncology findings hint at the role of excessive glucose in cancer progression and immune cells’ suppression. Sequel to this revelation is ongoing rese...
Saved in:
Main Authors: | Alblowy, Abeer Hamdan, Maan, Normah, Ibrahim, Abdulkareem Afolabi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier Ltd
2023
|
Subjects: | |
Online Access: | http://eprints.utm.my/106427/1/NormahMaan2023_OptimalControlStrategiesforSGLT2Inhibitors.pdf http://eprints.utm.my/106427/ http://dx.doi.org/10.1016/j.compbiomed.2023.107552 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stability and sensitivity analysis of tumor-induceimmune suppression with time delay
by: Ibrahim, Abdulkareem Afolabi, et al.
Published: (2020) -
Role of glucose risk factors on human breast cancer: a nonlinear dynamical model evaluation
by: Alblowy, Abeer Hamdan, et al.
Published: (2022) -
A dual-aggressive model of tumor-immune system interactions
by: Afolabi, Abdulkareem Ibrahim, et al.
Published: (2019) -
Delay model of tumor-immune system interactions with hyperthermia treatment
by: Ibrahim, AbdulKareem Afolabi
Published: (2023) -
Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND): A randomised, double-blind, crossover trial
by: Cherney, David Z., et al.
Published: (2020)